0RAR Stock Overview
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Stratec SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €41.90 |
| 52 Week High | €69.00 |
| 52 Week Low | €36.05 |
| Beta | 0.13 |
| 1 Month Change | 0.30% |
| 3 Month Change | 2.94% |
| 1 Year Change | -31.36% |
| 3 Year Change | -62.96% |
| 5 Year Change | -33.12% |
| Change since IPO | -13.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RAR | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 7.3% | 2.1% | 2.3% |
| 1Y | -31.4% | -9.3% | 0.6% |
Return vs Industry: 0RAR underperformed the UK Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: 0RAR underperformed the UK Market which returned 0.3% over the past year.
Price Volatility
| 0RAR volatility | |
|---|---|
| 0RAR Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0RAR has not had significant price volatility in the past 3 months.
Volatility Over Time: 0RAR's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 1,480 | Marcus Wolfinger | www.stratec.com |
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Stratec SE Fundamentals Summary
| 0RAR fundamental statistics | |
|---|---|
| Market cap | €504.47m |
| Earnings (TTM) | €13.07m |
| Revenue (TTM) | €261.91m |
38.6x
P/E Ratio1.9x
P/S RatioIs 0RAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RAR income statement (TTM) | |
|---|---|
| Revenue | €261.91m |
| Cost of Revenue | €197.07m |
| Gross Profit | €64.85m |
| Other Expenses | €51.78m |
| Earnings | €13.07m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 1.07 |
| Gross Margin | 24.76% |
| Net Profit Margin | 4.99% |
| Debt/Equity Ratio | 53.6% |
How did 0RAR perform over the long term?
See historical performance and comparisonDividends
1.3%
Current Dividend Yield51%
Payout RatioDoes 0RAR pay a reliable dividends?
See 0RAR dividend history and benchmarks| Stratec dividend dates | |
|---|---|
| Ex Dividend Date | May 20 2024 |
| Dividend Pay Date | May 22 2024 |
| Days until Ex dividend | 24 days |
| Days until Dividend pay date | 26 days |
Does 0RAR pay a reliable dividends?
See 0RAR dividend history and benchmarks